Silicone Valley Bank: Trends in Healthcare Investments and Exits 2018

04-Nov-2018

A recent report by SVB highlights Civilization Ventures on page 19:

Almost any way you look at it, 2018 was a record year for life science and healthcare companies. We saw new levels of venture fundraising, total investment values, acquisitions and initial public offerings.

Highlights in 2018 include:

  • US healthcare venture fundraising reaches $9.6 billion —a record.
  • US and EU VC investment in life science and healthcare companies surges 50 percent, with biopharma dominating.
  • Biopharma total exit deal value hits $49 billion, including 18 deals valued at more than $1 billion.
  • Device M&A activity increases and IPOs double.
  • Diagnostics/Tools rebound with 10 acquisitions and two high-profile IPOs.

Download the report to get SVB’s proprietary analysis and outlook for 2019.

Read the full publication